T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSTL
2501
Postal Realty Trust
PSTL
$701M
| $211K | ﹤0.01% |
14,553
-593
| -4% | -$9.04K |
|
2502
Vaalco Energy
EGY
$592M
| $210K | ﹤0.01% |
46,076
+9,105
| +25% | +$45.7K |
|
2503
Liquidity Services
LQDT
$1.35B
| $209K | ﹤0.01% |
14,863
+329
| +2% | +$5.28K |
|
|
TCS
2504
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $209K | ﹤0.01% |
3,227
+856
| +36% | +$62K |
|
|
TIG
2505
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $209K | ﹤0.01% |
34,793
+866
| +3% | +$3.01K |
|
2506
Beam Global
BEEM
$25.5M
| $208K | ﹤0.01% |
11,900
| – | – |
|
|
CIO
2507
DELISTED
City Office REIT
CIO
| $208K | ﹤0.01% |
24,768
+300
| +1% | +$2.89K |
|
2508
First Internet Bancorp
INBK
$256M
| $208K | ﹤0.01% |
+8,580
| New | +$227K |
|
2509
Clover Health Investments
CLOV
$2.38B
| $207K | ﹤0.01% |
223,203
+5,269
| +2% | +$7.03K |
|
2510
Fulgent Genetics
FLGT
$513M
| $207K | ﹤0.01% |
6,947
+316
| +5% | +$11.3K |
|
2511
SmartRent
SMRT
$276M
| $207K | ﹤0.01% |
85,043
-177,515
| -68% | -$439K |
|
2512
Employers Holdings
EIG
$871M
| $206K | ﹤0.01% |
+4,778
| New | +$197K |
|
2513
Levi Strauss
LEVI
$8.63B
| $206K | ﹤0.01% |
13,300
-2,500
| -16% | -$38.8K |
|
2514
Aurora
AUR
$13.4B
| $205K | ﹤0.01% |
168,992
+23,900
| +16% | +$40.8K |
|
2515
Codexis
CDXS
$175M
| $205K | ﹤0.01% |
43,890
+1,176
| +3% | +$6.45K |
|
2516
iShares MSCI EAFE Value ETF
EFV
$30.1B
| $205K | ﹤0.01% |
+4,462
| New | +$194K |
|
2517
UNIFI
UFI
$120M
| $205K | ﹤0.01% |
+23,838
| New | +$205K |
|
2518
Cytek Biosciences
CTKB
$636M
| $204K | ﹤0.01% |
19,976
+1,573
| +9% | +$21.1K |
|
|
OLP
2519
One Liberty Properties
OLP
$537M
| $204K | ﹤0.01% |
9,162
-5,701
| -38% | -$131K |
|
|
BLUE
2520
DELISTED
bluebird bio
BLUE
| $202K | ﹤0.01% |
1,457
+46
| +3% | +$6.48K |
|
|
ACCD
2521
DELISTED
Accolade Inc
ACCD
| $202K | ﹤0.01% |
25,890
+3,530
| +16% | +$33.7K |
|
|
NGM
2522
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $202K | ﹤0.01% |
40,187
+6,242
| +18% | +$39.1K |
|
|
LOVE
2523
LoveSac
LOVE
$258M
| $201K | ﹤0.01% |
9,118
-7,059
| -44% | -$158K |
|
|
KLRS
2524
Kalaris Therapeutics
KLRS
$92.4M
| $201K | ﹤0.01% |
1,701
-445
| -21% | -$75.5K |
|
2525
Compass Diversified
CODI
$924M
| $200K | ﹤0.01% |
+10,996
| New | +$206K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.